Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. - Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH; Bouxsein, Mary L; Chen, Peiqi; Glass, Emmett V; Kallmes, David F; Delmas, Pierre D; Mitlak, Bruce H (Journal of Bone & Joint Surgery, American Volume, 2009)